Earnings Call · Q4 FY2025·2026-02-12

Q4 25EPS +5.13%·Rev n/aQ3 25EPS +6.32%·Rev n/aQ2 25EPS -10.29%·Rev n/aQ1 25EPS +11.93%·Rev n/a⚠ consensus missing

AGIOS PHARMACEUTICALS, INC. AGIO

Morgan Sanford — Chief Financial Officer

Brian Goff — Chief Executive Officer

Cecilia Jones — Chief Commercial Officer

+1.3%1d on move date+2.8% vs SPY3d+0.4%5d+3.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AGIO calls or request research access.

More AGIO calls Browse calls Request research access